Search

everythinglearnresearchcommunity

for

Search:↓

Severe alopecia areata in South Korea has a high treatment burden, with most patients needing multiple treatments and frequent doctor visits.

JAK inhibitors like tofacitinib may effectively treat alopecia in children without major side effects.

The Fas/FasL pathway may play a role in alopecia areata.

Excimer laser can effectively treat mild to moderate patchy alopecia areata.

Alopecia areata greatly affects quality of life, especially mental health, and newer assessment tools better capture this impact than older ones.

Topical tofacitinib is effective and safe for treating alopecia areata.

Severe alopecia areata patients have a low chance of spontaneous hair regrowth.

A change in SALT scores of 42 or 43 indicates meaningful improvement in alopecia areata treatment.

Diphenylcyclopropenone is effective and safe for treating severe alopecia areata in children, with maintenance therapy reducing relapse risk.

IBD patients treated with TNF antagonists may develop autoimmune alopecia areata, with severe cases less likely to improve.

Children with alopecia areata in Singapore generally have a good quality of life.

Baricitinib quickly improved severe alopecia areata, with almost total hair regrowth in three months.

Phosphorus homeopathy treatment led to complete hair regrowth in two Alopecia Areata patients.

Severe alopecia areata greatly impacts quality of life, mental health, and daily activities.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Secukinumab can cause hair loss, which may improve after stopping the medication.

Most alopecia areata patients in the study were women, aged 15-49, with patchy hair loss and often had other health conditions.

Blocking the protein CXCL12 with a specific antibody can increase hair growth in common hair loss conditions.

PRP therapy significantly regrows hair and satisfies patients without side effects.

New drugs, baricitinib and ritlecitinib, are effective for severe alopecia areata.

More research is needed to understand genetic causes and create better treatments for alopecia areata.

Recognizing perinevoid alopecia and concentric regrowth is important for diagnosing and treating alopecia areata.

Ayurvedic treatment, including leech therapy, can effectively regrow hair in alopecia areata.

Transverse sectioning is more reliable for diagnosing alopecia areata.

Accurate diagnosis of alopecia areata incognito requires trichoscopy and histopathology.

Severe alopecia areata in children can signal future autoimmune issues.

Trichoscopy is essential for diagnosing and managing alopecia areata in children.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.